Evidence map›Paper›PMID 35008259›Full record

ReviewCancers2021

Orbital Metastases: A Systematic Review of Clinical Characteristics, Management Strategies, and Treatment Outcomes.

Paolo Palmisciano, Gianluca Ferini, Christian Ogasawara, Waseem Wahood, Othman Bin Alamer, Aditya D Gupta, Gianluca Scalia, Alexandra M G Larsen, Kenny Yu, Giuseppe E Umana and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 3 countries.

Paolo PalmiscianoDepartment of Neurosurgery, Trauma Center, Gamma Knife Center, Cannizzaro Hospital, 95126 Catania, Italy.ORCID 0000-0003-0711-3975
Gianluca FeriniDepartment of Radiation Oncology, REM Radioterapia srl, 95029 Viagrande, Italy.
Christian OgasawaraJohn A. Burns School of Medicine, University of Hawai'i, Honolulu, HI 96813, USA.
Waseem WahoodKiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Davie, FL 33328, USA.
Othman Bin AlamerDepartment of Neurosurgery, King Abdullah International Medical Research Center, Riyadh 11451, Saudi Arabia.ORCID 0000-0001-9365-4115
Aditya D GuptaCollege of Medicine, Texas A&M University, Houston, TX 77030, USA.
Gianluca ScaliaDepartment of Neurosurgery, Highly Specialized Hospital and of National Importance "Garibaldi", 95126 Catania, Italy.ORCID 0000-0002-9465-2506
Alexandra M G LarsenDepartment of Neurosurgery, Brain Metastasis Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Kenny YuDepartment of Neurosurgery, Brain Metastasis Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Giuseppe E UmanaDepartment of Neurosurgery, Trauma Center, Gamma Knife Center, Cannizzaro Hospital, 95126 Catania, Italy.ORCID 0000-0002-1573-431X
Aaron A Cohen-GadolDepartment of Neurological Surgery, Indiana University School of Medicine, Indianapolis, IN 46077, USA.
Tarek Y El AhmadiehDepartment of Neurosurgery, Brain Metastasis Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Ali S HaiderCollege of Medicine, Texas A&M University, Houston, TX 77030, USA.
Memorial Sloan Kettering Cancer Center · USOspedale Cannizzaro · ITKing Abdullah International Medical Research Center · SANeurological Surgery · USNova Southeastern University · USOspedale Garibaldi · ITTexas A&M University · USThe University of Texas MD Anderson Cancer Center · USUniversity of Hawaiʻi at Mānoa · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundOrbital metastases often lead to severe functional impairment. The role of resection, orbital exenteration, and complementary treatments is still debated. We systematically reviewed the literature on orbital metastases.

methodsPubMed, Scopus, Web-of-Science, and Cochrane were searched upon PRISMA guidelines to identify studies on orbital metastases. Clinical characteristics, management strategies, and survival were analyzed.

resultsWe included 262 studies comprising 873 patients. Median age was 59 years. The most frequent primary tumors were breast (36.3%), melanoma (10.1%), and prostate (8.5%) cancers, with median time interval of 12 months (range, 0-420). The most common symptoms were proptosis (52.3%) and relative-afferent-pupillary-defect (38.7%). Most metastases showed a diffuse location within the orbit (19%), with preferential infiltration of orbital soft tissues (40.2%). In 47 cases (5.4%), tumors extended intracranially. Incisional biopsy (63.7%) was preferred over fine-needle aspiration (10.2%), with partial resection (16.6%) preferred over complete (9.5%). Orbital exenteration was pursued in 26 patients (3%). A total of 305 patients (39.4%) received chemotherapy, and 506 (58%) received orbital radiotherapy. Post-treatment symptom improvement was significantly superior after resection (

conclusionsOrbital metastases severely impair patient quality of life. Surgical resection safely provides symptom and survival benefit compared to biopsy, while orbital radiotherapy significantly improves symptoms compared to not receiving radiotherapy.

Indexed as

orbital exenterationorbital metastasesradiation oncologyskull base oncologysystematic review

Identifiers

PMID35008259
PMCPMC8750198
OpenAlexW4200064951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.